menu
    • menu

    Company profile for Asieris Pharmaceuticals

    NEW Drugs in Dev: 7
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Asieris Pharmaceuticals, founded in March 2010 in China Medical City in Jiangsu Taizhou, is the only China-based, globally oriented company specializing in the R&D of new drugs for the treatment of genitourinary tumors and related diseases. Our professional teams are located in Shanghai, Beijing, and Taizhou (Jiangsu), as well as in the United States, with departments responsible for domestic and international clinical develop...
    Asieris Pharmaceuticals, founded in March 2010 in China Medical City in Jiangsu Taizhou, is the only China-based, globally oriented company specializing in the R&D of new drugs for the treatment of genitourinary tumors and related diseases. Our professional teams are located in Shanghai, Beijing, and Taizhou (Jiangsu), as well as in the United States, with departments responsible for domestic and international clinical development, regulatory affairs, pharmaceutical sciences, new drug discovery, and business development.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Asieris PharmaceuticalsChina Flag
    Country
    Country
    China
    Address
    Address
    12th Floor, Building 56, Jinling Capital, No, 1000, Jinhai Road, Pudong New Ar...
    Telephone
    Telephone
    + (86) 021-6858-5280
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.asieris.cn/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/asieris-pharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Asieris’ CEVIRA Wins China Approval for Cervical Precancer
    Asieris’ CEVIRA Wins China Approval for Cervical Precancer

    03 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/asieris-cevira-approved-in-china-as-first-in-class-non-invasive-therapy-for-cervical-precancerous-lesions-302702336.html

    PR NEWSWIRE
    03 Mar 2026
    Share Share
    CEVIRA Approved in China for Cervical Precancer Lesions
    CEVIRA Approved in China for Cervical Precancer Lesions

    03 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/asieris-cevira-approved-in-china-as-first-in-class-non-invasive-therapy-for-cervical-precancerous-lesions-302702287.html

    PR NEWSWIRE
    03 Mar 2026
    Share Share
    EMA Accepts MAA for Photocure Partner Asieris’ CEVIRA
    EMA Accepts MAA for Photocure Partner Asieris’ CEVIRA

    27 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/photocure-partner-asieris-announces-that-ema-has-accepted-marketing-authorization-application-for-cevira-in-europe-302699506.html

    PR NEWSWIRE
    27 Feb 2026
    Share Share
    Asieris Reports 2025 Semi-Annual Results, Innovation Pipeline
    Asieris Reports 2025 Semi-Annual Results, Innovation Pipeline

    28 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/asieris-pharmaceuticals-releases-2025-semi-annual-report-with-sustained-commercial-momentum-and-breakthrough-innovation-poised-for-launch-302540929.html

    PR NEWSWIRE
    28 Aug 2025
    Share Share
    Asieris Pharmaceuticals 2024 Annual Report: Revenue Tops RMB 200M
    Asieris Pharmaceuticals 2024 Annual Report: Revenue Tops RMB 200M

    18 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/asieris-pharmaceuticals-releases-2024-annual-report-with-revenue-exceeding-rmb-200m-in-1st-year-of-commercialization-and-innovative-portfolio-accelerating-toward-launch-302432475.html

    PR NEWSWIRE
    18 Apr 2025
    Share Share
    Asieris & CDC Sign Supply Agreement For APL-1202 In Amoeba Treatment
    Asieris & CDC Sign Supply Agreement For APL-1202 In Amoeba Treatment

    06 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/asieris-and-cdc-sign-investigational-product-supply-agreement-for-apl-1202-in-free-living-amoeba-infections-treatment-under-expanded-access-investigational-new-drug-program-302342872.html

    PR NEWSWIRE
    06 Jan 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search